Tarsus Pharmaceuticals
The Director, Formulation Development leads oral drug product development across the Tarsus portfolio, reporting to the VP of Manufacturing Operations & Supply Chain. This role is responsible for the scientific strategy and execution of oral formulation and process development through external partners, as well as the leadership and development of internal personnel. The position ensures that formulations, manufacturing processes, and clinical supply plans are scientifically sound, scalable, and aligned with program objectives from preclinical development through Phase 3.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
8% above the average for this role
Senior Scientist 1, Drug Product Development
Crinetics Pharmaceuticals
Senior Formulation Scientist
Hims
Sr. Research Associate, Drug Product Development
Crinetics Pharmaceuticals
Formulation and Process Development Scientist
Revolution Medicines
Formulation Chemist
K2 Staffing
Formulation Project Leader (Early Phase)
Novartis